Ardelyx Touts IBSRELA's 73% Growth, Reaffirms $1B 2029 Goal and Details CIC Phase III Plan [Yahoo! Finance]
Ardelyx, Inc. (ARDX)
Last ardelyx, inc. earnings: 3/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ardelyx.com/investor-relations
Company Research
Source: Yahoo! Finance
Ardelyx (NASDAQ:ARDX) executives outlined commercial momentum for IBSRELA and XPHOZAH, key investment priorities for 2026, and development plans for a chronic idiopathic constipation (CIC) expansion at a Global Healthcare Conference, highlighting what management characterized as improving execution and increasing confidence in long-term growth targets. Commercial update: IBSRELA growth and 2026 priorities Chief Commercial Officer Eric Foster said IBSRELA delivered 73% growth in 2025 , which he said strengthened the company's confidence entering 2026. Foster described 2025 as a year focused on execution, noting the company “beat and raised” guidance for IBSRELA multiple times during the year. ? 3 European Stocks for Riding Out Market Volatility Is Ardelyx is A Buy After Slip in Early 2022 Looking to 2026, Foster said Ardelyx's commercial priorities include continuing to accelerate IBSRELA momentum and optimizing its expanded sales force. He said the company doubled its sales
Show less
Read more
Impact Snapshot
Event Time:
ARDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARDX alerts
High impacting Ardelyx, Inc. news events
Weekly update
A roundup of the hottest topics
ARDX
News
- Ardelyx (ARDX) was given a new $17.00 price target by Williams Trading.MarketBeat
- Ardelyx (ARDX) had its "outperform" rating reaffirmed by Leerink Partners.MarketBeat
- Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award [Yahoo! Finance]Yahoo! Finance
- Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate AwardGlobeNewswire
- Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C [Yahoo! Finance]Yahoo! Finance
ARDX
Earnings
- 2/19/26 - Miss
ARDX
Sec Filings
- 2/25/26 - Form 4
- 2/24/26 - Form 144
- 2/23/26 - Form 4
- ARDX's page on the SEC website